Lago 1998.
Study characteristics | ||
Methods | Single‐centre randomised double‐blind controlled trial | |
Participants | 55 preterm infants (26 to 34 weeks) requiring mechanical ventilation for hyaline membrane disease, with indwelling catheters
Exclusion criteria: asphyxia (Apgar < 5 at 5 minutes); foetal drug exposure; sepsis; major congenital anomalies 2 infants died (1 in fentanyl group and 1 in control group) and were excluded from analysis |
|
Interventions | Fentanyl group (n = 26): continuous infusion at 0.5 to 2 mcg/kg/hour adjusted to render the neonate sedated but arousable (according to the behavioural sedation score) Control group (n = 27): no intervention | |
Outcomes | Urine metanephrine:normetanephrine molar ratio concentration; behavioural sedation score (assessed every 2 hours during the study period); severity of hyaline membrane disease; need for surfactant replacement; evidence of clinically significant patent ductus arteriosus; days of ventilatory support and oxygen treatment; air leak; IVH; PVL; BPD; days to exclusive enteral feeding; days to reach birth weight; length of hospital stay | |
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Method of randomisation was not stated |
Allocation concealment (selection bias) | Low risk | The use of sealed envelopes was reported (study author's communication) |
Blinding of participants and personnel (performance bias) | High risk | Caregivers were not blinded |
Blinding of outcome assessment (detection bias) | Unclear risk | Assessors were stated to be blinded to treatment, but blinding was unlikely |
Incomplete outcome data (attrition bias) | High risk | 2 patients died after enrolment and were excluded from statistical analysis |
Selective reporting (reporting bias) | Unclear risk | Trial not registered; protocol not available |
Other bias | Low risk | Study appears to be free of other sources of bias |